First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI

Magnetic Resonance in Medical Sciences

Volumn 2, Issue 2, 2003, Pages 61-69

  Matsunaka, Tsuyoshi ^a   Hamada, Mareomi ^a   Matsumoto, Yuji ^b   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saijo Central Hospital   (Japan)

Author keywords

Delayed contrast enhancement; First pass myocardial perfusion defect; Hypertrophic cardiomyopathy; Magnetic resonance imaging; Myocardial fibrosis

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; FEMALE; HEART CONTRACTION; HEART INFARCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION;

EID: 2942713241     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.2.61     Document Type: Article

References (32)

1. Cohen MV, Cooperman LB, Rosenblum R. Regional myocardial function in idiopathic hypertrophic subaortic stenosis. An echocardiographic study. Circulation 1975; 52:842-847.
2. Yoshida M, Takamoto T. Left ventricular hypertrophic patterns and wall motion dynamics in hypertrophic cardiomyopathy: an electron beam computed tomographic study. Intern Med 1997; 39:263-269.
3. Mishiro Y, Oki T, Iuchi A, et al. Regional left ventricular myocardial contraction abnormalities and asynchrony in patients with hypertrophic cardiomyopathy evaluated by magnetic resonance spatial modulation of magnetization myocardial tagging. Jpn Circ J 1999; 63:442-446.
4. Frielingsdorf J, Franke A, Kühl HP, Hess OM, Flachskampf FA. Evaluation of septal hypertrophy and systolic function in disease that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr 2001; 14:370-377.
5. Pouleur H, Rousseau MF, van Eyll C, Brasseur LA, Charlier AA. Force-velocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility. Am J Cardiol 1983; 52:813-817.
6. Silverman KJ, Hutchins GM, Weiss JL, Moore GW. Catenoidal shape of the interventricular septum in idiopathic hypertrophic subaortic stenosis: two dimensional echocardiographic confirmation. Am J Cardiol 1982; 49:27-32.
7. Sandstede JJ, Lipke C, Beer M, et al. Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. Am J Roentgenol 2000; 174:1737-1740.
8. 1-weightedMR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging 2000; 11:476-480.
9. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992-2002.
10. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
11. Nishimura T, Yamada N, Haze K, Nagata S. Experience using gadolinium-DTPA in cardiovascular MRI. Magn Reson Med 1991; 22:354-357.
12. Tsukihashi H, Ishibashi Y, Shimada T, et al. Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopahty. (in Japanese with English abstract) J Cardiol 1994; 24:185-191.
13. Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 2002; 29: 176-180.
14. Richardson P, McKenna W, Bristow M, et al. Report of theWorld Health OrganizationWInternational Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93:841-842.
15. Arai AE. Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 2000; 11:383-398.
16. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 1984; 142:619-624.
17. Schmiedl U, Moseley ME, Ogan MD, Chew WM, Brasch RC. Comparison of initial biodistribution patterns of Gd-DTPA and albumin-(Gd-DTPA) using rapid spin echo MR imaging. J Comput Assist Tomogr 1987; 11:306-313.
18. Akisawa M, Matsumura Y, Kitaoka H, Yamasaki N, Takata J, Doi Y. Myocardial enhancement on magnetic resonance imaging with gadoliniumdiethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy. J Cardiol 2002; 40:145-152.
19. Schaefer S, Malloy CR, Katz J, et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol 1988; 12:1064-1072.
20. Matsuoka H, Hamada M, Honda T, et al. Precise assessment of myocardial damage associated with secondary cardiomyopathies by use of Gd-DTPAenhanced magnetic resonance imaging. Angiology 1993; 44:945-950.
21. Fujiwara H, Hoshino T, Fujiwara T, Kawai C, Hamashima Y. Classification and distribution of myocardial fascicle and fiber disarray in 14 hearts with hypertrophic cardiomyopathy in 25 μ thick sections. Jpn Circ J 1982; 46:225-234.
22. Aso H, Takeda K, Ito T, Shiraishi T, Matsumura K, Nakagawa T. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 1998; 33:22-32.
23. Nanjo S, Yamazaki J, Yoshikawa K, Miura M, Seno A. Efficacy of contrast-enhanced MR imaging in cardiomyocathy: an experimental study using Bio14.6 hamsters. Acad Radiol 2002; 9: 1139-1147.
24. Yamakado K, Takeda K, Sakuma H, et al. Tissue characterization by magnetic resonance imaging with Gd-DTPA enhancement in hypertrophic cardiomyopathy. (in Japanese with English abstract) Jpn J Magn Reson Med 1991; 11:75-82.
25. Weiss MB, Ellis K, Sciacca RR, Johnson LL, Schmidt DH, Cannon PJ. Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation 1976; 54:484-494.
26. Bonow RO, Frederick TM, Bacharach SL, et al. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol 1983; 51:1386-1391.
27. 201Tl myocardial scintigraphy and coronary blood flow velocity in patients with hypertrophic cardiomyopathy. (in Japanese) Shinzo 1992; 24 (Suppl):33-38.
28. Cannon RO III, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circularion 1985; 71:234-243.
29. Kawada N, Sakuma H, Yamakado T, et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999; 211:129-135.
30. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8:545-557.
31. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986; 55:575-581.
32. Rossen RM, Goodman DJ, Ingham RE, Popp RL. Ventricular systolic septal thickening and excursion in idiopathic hypertrophic subaortic stenosis. N Engl J Med 1974; 291:1317-1319.